SCHEMBL462589

SCHEMBL462589

Cc1ccc(-c2c(C(C)(O)C(=O)O)c(C)nc3cc(-c4ccccc4)nn23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.52
HPGD P15428 6/20 0.52
NPC1 O15118 5/20 0.52
RAB9A P51151 5/20 0.52
ALDH1A1 P00352 5/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
GAA P10253 3/20 0.52
CYP2C19 P33261 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAPT P10636 7/20 0.47
NFKB1 P19838 1/20 0.46
HTT P42858 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
TP53 P04637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16457723 0.84 KDM4E (0.50) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL461595 0.76 KDM4E (0.55) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL461844 0.76 KDM4E (0.53) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL10174452 0.76 NR1I2 (0.62) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL461032 0.75 NPC1 (0.57) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL462715 0.75 KDM4E (0.57) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL16457557 0.74 AURKA (0.40) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL460972 0.74 NR1I2 (0.54) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL461196 0.73 KDM4E (0.52) KDM4EHPGDNPC1RAB9AALDH1A1
SCHEMBL2047251 0.73 PSIP1 (0.66) KDM4EHPGDNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614064-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2013-07-17 EP disclosed
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed